ClinicalTrials.Veeva

Menu

Wellness Interventions After Transplant Study (WIAT)

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 3

Conditions

Organ Transplant

Treatments

Behavioral: Delayed Intervention
Behavioral: Health Education (HE)
Behavioral: Mindfulness-Based Stress Reduction (MSBR)

Study type

Interventional

Funder types

NIH

Identifiers

NCT00367809
GCRC Protocol 942

Details and patient eligibility

About

The Wellness Interventions after Transplant (WIAT) Trial has reached its enrollment target. This trial is no longer recruiting new patients. Those currently enrolled will be followed for a year to evaluate trial outcomes.

The purpose of this trial is to determine if training in Mindfulness-Based Stress Reduction can reduce symptom distress and improve quality of life in solid organ transplant recipients. Primary study outcomes are depression, anxiety and insomnia symptoms, measured by well-validated self-report scales. The impact of this program on objectively measured sleep outcomes, use of health care resources and costs will also be evaluated.

Full description

Pharmacologic options for managing symptoms increase the risks of side effects and drug interactions, and may reduce adherence by complicating an already challenging medication regimen. In contrast, mind-body based complementary therapies may be ideal to treat distressing symptoms and negative emotions after transplantation. Our long-range objective is to develop evidence-based recommendations for non-pharmacologic strategies that provide symptom relief to transplant recipients, and are safe, practical and cost-effective.

Potential participants are recruited by mail, screening by clinic staff and provider referrals. Interested persons are screened by telephone and mailed informational study brochures. Informed consent is conducted by face-to-face interview, where a diagram of the study design is used to explain the 2-stage randomization and study requirements.

Enrollment

140 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • kidney, kidney/pancreas, pancreas, lung, liver, heart or heart-lung recipients, with a functioning graft
  • 18 years old or older
  • English-speaking
  • literate
  • mentally intact
  • reachable by telephone
  • on immune suppressive medication
  • receiving regular medical follow-up care
  • interested in health promotion and mind-body interventions
  • able to attend weekly classes in a Minnesota Metro area
  • willing to complete the informed consent process

Exclusion criteria

  • serious preexisting mental health issues such as suicide attempts or a psychosis
  • medically unstable (a hospital admission for non-elective purposes in the last 3 months or major surgery planned in the next 3 months)
  • on dialysis
  • regularly practicing mindfulness meditation

Trial design

140 participants in 3 patient groups

1
Experimental group
Treatment:
Behavioral: Mindfulness-Based Stress Reduction (MSBR)
2
Active Comparator group
Treatment:
Behavioral: Health Education (HE)
3
No Intervention group
Treatment:
Behavioral: Delayed Intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems